Thrombolysis in acute ischaemic stroke - time for a rethink?

episode

Medicine and Science from The BMJ not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Obsolete or Irreplaceable? Garrison Lovely on Stopping the Race to Replace Human Labor 2h 13m · 29 Sep 2026 · "The Cognitive Revolution"

Mission: Impossible 47 min · 29 Sep 2026 · I've Had It

THE DISCLAIMER: Summer Wardrobe Planning 12 min · 29 Sep 2026 · The Hauraki Big Show

Squiz Shortcuts: What’s an AI agent? 12 min · 29 Sep 2026 · Squiz Today

FULL SHOW: The Big Show Travel Guide 57 min · 29 Sep 2026 · The Hauraki Big Show

LVST 29 de septiembre de 2026 1h 10m · 29 Sep 2026 · La Venganza Será Terrible (oficial)

Report any issue

Source

Recorded18 Mar 2015

Publisherfeed.podbean.com ↗

Handlerec:13498619

Show notes

In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours. In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours. Read their full analysis: http://www.bmj.com/content/350/bmj.h1075

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in